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Dendritic cells cells induce immunity or—in the steady state—maintain peripheral tolerance. Little is known in that
regard about Langerhans cells. Therefore, we investigated migrating Langerhans cells in the steady-state versus
inﬂammation. Increased numbers of Langerhans cells, as determined by immunostaining for Langerin/CD207,
appeared in the lymph nodes in response to a contact allergen. Whereas a large proportion of Langerhans cells
expressed CD86 in the steady state, CD40, and CD80 were found on a smaller percentage. During inﬂammation,
more CD40þ , CD80þ , CD274/B7-H1/PD-L1þ , and CD273/B7-DC/PD-L2þ Langerhans cells were found in the lymph
nodes, and they expressed higher levels of these molecules. CD275/inducible T cell co-stimulator (ICOS) ligand
was not detected. Langerhans cells in the nodes of contact allergen-treated mice produced more IL-12p40/70. This
correlated with more interferon-c being produced by activated lymph node T cells. Epicutaneous immunization with
ovalbumin under inﬂammatory conditions led to a more vigorous proliferation of antigen-speciﬁc CD4 T cells
in vitro and in vivo as compared with immunization in the steady state. The latter modality, however did not induce
strong CD4 T cell tolerance in this model. Thus, the overall phenotype of Langerhans cells is not an indicator for
their immunogenic or tolerogenic potential.
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Dendritic cells (DC) primarily induce immunity. During the
last few years, however, it has become apparent that DC
also play a role in the maintenance of tolerance (Heath and
Carbone, 2001; Steinman et al, 2003). How the cells can
perform these two opposing roles is still under investigation.
There is evidence that in the steady state DC induce
tolerance to specific antigens targeted to the cells via the
lectin receptor DEC-205/CD205. Simultaneous injection of a
maturation-inducing anti-CD40 monoclonal antibody (mAb)
overcame the tolerogenic situation and induced immunity
against that same antigen (Hawiger et al, 2001; Bonifaz
et al, 2002). An elegant model with a Cre/LoxP system in
which antigen expression could be induced in DC in vivo at
any point in time was used by Probst and coworkers to
further complement these data. When mice were immu-
nized with antigen in the steady state, antigen-specific tol-
erance could be observed; it was broken when mice were
co-injected with a maturation-inducing anti-CD40 mAb
(Probst et al, 2003). Together, these data suggest that
non-activated immature DC in the steady state induce tol-
erance whereas activated, fully mature DC generate immu-
nity. The properties of Langerhans cells (LC), the epidermal
variant of DC (Romani et al, 2003; Wilson and Villadangos,
2004), have not yet been specifically studied in that regard.
Several reports have investigated the phenotype of DC in
lymph nodes (LN), with special regard to skin-derived pop-
ulations (Salomon et al, 1998; Ruedl et al, 2000; Henri et al,
2001). In these studies, skin-derived DC in LN were char-
acterized after application of a cell tracer onto the epidermis
as large cells expressing DEC-205/CD205, E-cadherin, Lan-
gerin/CD207, and co-stimulatory molecules. Ruedl et al
(2001) and Hawiger et al (2001) demonstrated that co-
stimulatory molecules could be further upregulated after
application of an inflammatory stimulus. Wilson et al (2003).
reported that the migratory skin-derived LN DC in the
steady state display a mature phenotype in that they ex-
press high levels of co-stimulatory molecules and major
histocompatibility complex- (MHC-) class II in contrast to
resident LN DC. In addition, it was demonstrated that LC
are critically involved in the transport of self-antigens from
the skin to draining LN in the steady state (Hemmi et al,
2001). Phenotypical and functional propertiesof such mi-
gratory LC, however, were not addressed in these studies.
Thus, we were interested to determine possible differ-
ences in phenotype and function of LC in LN during inflam-
mation as compared with a steady-state situation. Langerin
is a C-type lectin receptor expressed by LC, which can bind
mannan and is involved in Birbeck granule formation (Val-
ladeau et al, 2000). Antibodies against murine Langerin al-
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low the direct and simple identification of LC in skin and in
LN (Valladeau et al, 2002) and we recently reported that LC
can be tracked on the basis of Langerin expression on their
way from the epidermis to the LN (Stoitzner et al, 2003). In
this study, we therefore used anti-Langerin mAb’s to inves-
tigate changes in LC migrating to the LN after induction of
inflammation in the skin.
Results
Inﬂammation in the skin by a contact allergen increases
the absolute numbers of LC in draining LN The single
application of the contact allergen TNCB (2,4,6-trinitro-1-
chlorobenzene) induced strong inflammation in the treated
skin area. The activated LC co-expressed CD40 and CD86
in the epidermis and started to emigrate from the epidermis
(data not shown, Weinlich et al, 1998). In accordance with
the emigration of LC from the TNCB-inflamed skin the
draining LN were swollen. When LN cell suspensions were
analyzed we observed that cellularity, i.e., total cell num-
bers, increased 2- to 3-fold. On LN sections it was not
possible to visualize the increased immigration of Lan-
gerinþ cells as the LC-densities varied between the sec-
tions. But when absolute numbers of LC were calculated,
based on hemocytometer-derived total cell numbers and
flow cytometry derived percentages of Langerinþ cells, we
observed higher numbers of LC 48 h after application of
contact allergen. With the mAb detecting intracellular Lan-
gerin (929F3), we observed about 1  104 LC per LN in
control mice as opposed to 2.5  104 LC in mice treated
with the contact allergen (Fig 1A). When we used a mAb
205C1 against cell surface Langerin we detected only one-
third of all LC, indicating that most of the LC had internal-
ized Langerin during migration to the LN. An increase in
numbers was observed in the inflammatory situation; how-
ever, the difference was not statistically significant (Fig 1B).
Furthermore, the total number of CD11cþDC was aug-
mented in contact allergen treated mice when compared
with untreated mice (Fig 1C). It should be mentioned that
similar increases were observed when contact allergen-
treated mice were compared with vehicle-treated mice.
The phenotype of LC in the LN changes in response to
inﬂammation Current evidence indicates that DC migrat-
ing to the LN in an immature or semi-mature (Menges et al,
2002) stage may induce tolerance in the steady state. Dur-
ing inflammation, however, DC acquire a fully mature phe-
notype and can induce an immune response to antigens
(Steinman and Nussenzweig, 2002). We therefore asked
whether this was similar when specifically addressing mi-
grating LC, rather than DC in general. We examined the
expression of co-stimulatory molecules CD40, CD80, CD86,
B7-H1 (PD-L1), B7-DC (PD-L2), and ICOS-ligand (inducible
T-cell co-stimulator ligand) on Langerinþ cells in LN cell
suspensions. In the steady state, a large proportion of LC in
the LN, as defined by the expression of intracellular La-
ngerin, co-expressed CD86, but only part of these cells
showed CD40, CD80, B7-H1, and B7-DC on their surface.
After application of a contact allergen onto the epidermis
more LC in the LN expressed CD40, CD86, B7-H1, and
B7-DC (Fig 2A). Similar results were obtained by immuno-
fluorescence analyses on sections from LN of TNCB-treat-
ed and control mice. Langerinþ cells were localized in T cell
areas and were mostly absent from B cell follicles as de-
scribed earlier (Stoitzner et al, 2003). Although occasional
Langerin-single-positive cells (i.e., immature LC) were vis-
ible, a large part of the Langerinþ cells co-expressed CD40
and CD86 (data not shown). Few Langerinþ cells in the LN
expressed B7-H1 and B7-DC in the steady state, whereas
during inflammation more LC expressing these molecules
Figure1
The contact allergen 2,4,6-trinitro-1-chlorobenzene (TNCB) induc-
es migration of Langerhans cells (LC) from the epidermis to the
skin-draining lymph node. Mice were treated with 1% TNCB, and 48
h later draining auricular and inguinal lymph nodes were taken. Cell
suspensions were prepared by collagenase digestion and total cell
numbers counted in the hemocytometer and stained with anti-Langerin
monoclonal antibodies (mAb) to determine percentages of LC among
all viable cells. From these data, absolute numbers of LC and dendritic
cells (DC) per lymph node were calculated. Numbers of (A) LC ex-
pressing Langerin intracellularly (mAb 929F3, mean  SD, n¼12); (B)
LC expressing Langerin molecules on the cell surface as detected by
the mAb to the extracellular part of Langerin (mAb 205C1, mean  SD,
n¼ 6); (C) CD11cþDC (mean  SD, n¼ 15). po0.005; po0.001;
N.S. not significant.
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were detectable on immunolabeled LN sections (data not
shown). Flow cytometry analyses revealed that LN LC still
expressing Langerin on the cell surface showed a more
mature phenotype with regard to the expression of co-
stimulatory molecules (Figure S1). When we investigated
the expression of co-stimulatory molecules on the cell sur-
face of resident and interstitium (dermis)-derived DC (i.e.,
Langerin DC) we observed their partial expression on
these subsets of DC, and some of these markers were up-
regulated during inflammation (Fig 2B). Extending these
observations, FACS analyses of LN cell suspensions
showed that not only the numbers of positive cells in-
creased but also expression levels of all co-stimulatory
molecules on LC in LN were higher during TNCB-induced
inflammation (Fig 3A). The tolerance-inducing co-stimula-
tory molecule ICOS-L was, however, never detected on LC
and only on a small fraction of the Langerin DC. This up-
regulation of expression levels was similar on the LC ex-
pressing Langerin either intra- or extracellularly (data not
shown). In contrast, when we examined the expression lev-
els of co-stimulatory molecules on the surface of Langerin
DC we observed only upregulation on part of the cells,
possibly dermal DC (Fig 3B).
More LC producing pro-inﬂammatory cytokines are
found in skin-draining LN during inﬂammation Next,
we studied cytokine expression patterns of LC in the LN in
the steady state versus inflammation. DC were isolated
from LN of TNCB-treated or control mice and examined by
flow cytometry for production of the cytokines interleukin
(IL)-12, IL-10, and tumor necrosis factor-a (TNF-a). DC
populations were stimulated with lipopolysaccharide (LPS)
plus an agonistic mAb against CD40 to increase cytokine
production. Without any stimulation of DC in vitro, some IL-
12p40/70 was detected in resident and interstitium (der-
mis)-derived DC (i.e., Langerin DC) as well as in LC (i.e.,
Langerinþ DC) in the draining LN. Proportionally more LC
than Langerin DC produced IL-12. After application of the
contact allergen TNCB onto the epidermis, LC in skin-
draining LN showed a significantly higher expression of IL-
12p40/70 as compared with the steady state and this was
not the case for Langerin DC (Fig 4A, Figure S2A). This
was also true when TNCB-treated mice were compared
with vehicle-treated mice. The pro-inflammatory cytokine
TNF-a was also examined. Only few LC as well as resident/
dermal DC produced TNF-a (0.9%–12% TNF-aþ DC/LC
per LN). During inflammation, TNF-a production was up-
regulated only in resident/dermal DC but not in LC of the
skin-draining LN. These differences, however, were not sta-
tistically significant (Fig 4B, Figure S2B). The anti-inflam-
matory cytokine IL-10 was also produced by resident/
dermal DC and LC in the skin-draining LN, again by small
numbers of cells (0.2%–7% IL-10þ DC/LC per LN). This
cytokine appeared not to be regulated during inflammation
(Fig 4C, Figure S2C).
T cells in skin-draining LN are activated and more T
cells produce interferon-c (IFN-c) during inﬂamma-
Figure 2
Numbers of mature Langerhans cells (LC) in skin-draining lymph nodes increase during inflammation. Lymph node cell suspensions were
labeled for Langerin (monoclonal antibodies (mAb) 929F3), CD11c, and co-stimulatory molecules CD40, CD80, CD86, B7-H1/PD-L1, B7-DC/PD-L2,
and ICOS-ligand (ICOS-L). The percentage of LC (CD11cþLangerinþ cells, A) and resident/dermal DC (CD11cþLangerin cells, B) positive for co-
stimulators was determined by flow cytometry. Experiments were carried out at least three times. Results are shown as mean  SD. po0.05;
po0.005; po0.001; N.S. not significant.
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tion Skin-draining LN swelled 48 h after application of the
contact allergen TNCB and total cell numbers increased
2–3-fold. Some of the CD3þ T cells expressed the IL-2 re-
ceptor CD25 (3%–10% of all T cells) and the early activation
marker CD69, thus indicating the presence of activated T
cells. After application of a contact allergen onto the skin
absolute numbers of CD25þ as well as CD69þ T cells in-
creased markedly in the LN draining the inflamed skin (Fig
5A). For examination of cytokine production, T cells were
additionally stimulated with anti-CD3 plus anti-CD28 mAb.
After stimulation, most of the T cells expressed the very
early antigen CD69 as well as CD25 (80%–90% of all Tcells,
data not shown) and IFN-g became clearly detectable.
When TNCB was applied onto the epidermis, significantly
more T cells produced IFN-g in the LN draining the inflamed
skin as compared with control mice in the steady state. This
increase in IFN-g expression was observed both in CD4þ
and in CD8þ T cells. The frequencies of CD8þ T cells pro-
ducing IFN-g were higher than those of their CD4þ coun-
terparts (Fig 5B, Fig S3). IL-4- or IL-10-producing T cells
were never detectable, neither in LN from control nor TNCB-
treated mice (data not shown).
Antigen-specific T cell proliferation is increased during
inﬂammation The difference in cytokine expression pat-
terns and the upregulation of co-stimulatory molecules on
LC in LN suggested an altered T cell stimulatory capacity of
LC in the inflammatory situation. Direct isolation of LC from
skin-draining LN was impossible as the Langerin mAb
929F3 only detects the intracellular molecule, and the mAb
205C1 against the extracellular Langerin would have al-
lowed sorting of only a part of the LC as the molecule dis-
appears from the cell surface on a large portion of LC during
their migration to the LN. Therefore, we sorted all CD11cþ
DC, including LC, from skin-draining LN with immunomag-
netic beads and co-cultured them with allogeneic T cells.
No difference was observed in stimulation of allogeneic T
cells between DC isolated from LN draining inflamed and
normal skin (data not shown). To further investigate possible
differences in T cell stimulatory capacity we used an anti-
gen-specific model to perform both in vitro and in vivo ex-
periments. To this end, ovalbumin (OVA) protein was applied
topically onto either untreated or TNCB-treated skin to tar-
get LC in the epidermis. For this purpose, the protein was
dissolved in phosphate-buffered saline (PBS) and then
mixed 1:1 with a creme to improve penetration into the skin.
This method enabled us to apply antigen onto undisturbed
skin. The draining auricular LN were collected 48 h later,
digested and CD11cþDC sorted with magnetic beads. DC
were co-cultured with OVA-specific T cells from OT-II mice
for 24–72 h to examine induction of Tcell proliferation. DC in
the skin-draining LN were able to present peptides on
Figure 3
Expression levels of co-stimulatory molecules increase in Langerhans cells during inflammation. Lymph node cell suspensions were pre-
pared 48 h after epicutaneous application of contact allergen and dendritic cells were enriched on a Nycodenz gradient. Cells were labeled for co-
stimulatory molecules, CD11c and Langerin (mAb 929F3), and gated on Langerinþ (A) or Langerin (B) cells. Expression levels of co-stimulatory
molecules in steady state (i.e., untreated mice) and during 2,4,6-trinitro-1-chlorobenzene (TNCB)-induced inflammation are shown. Bold line, TNCB-
treated mice; thin line, untreated control mice; dotted line, isotype control. Experiments were carried out at least three times.
MIGRATING LANGERHANS CELLS IN THE STEADY STATE 119125 : 1 JULY 2005
MHC-class II to antigen-specific T cells in vitro. Induction of
inflammation in the skin with contact allergen resulted in
markedly higher proliferation of antigen-specific T cells
in vitro. Notably, some antigen-specific proliferation of T
cells was also observed with DC from epicutaneously im-
munized but otherwise untreated mice (Fig 6A). Different
concentrations of OVA (100 mg–1 mg) gave similar results
(data not shown). As some activation of DC by the isolation
procedure itself could not be ruled out, in vivo proliferation
assays were performed. CFSE-labeled antigen-specific OT-
II T cells were transferred into mice 24 h prior to application
of OVA protein onto the epidermis, which was either un-
treated or TNCB-treated. After 3 d, the skin-draining LN
were examined for in vivo proliferation of antigen-specific T
cells. Following application of PBS, i.e., in the absence of
antigen and inflammation, we never observed proliferation
of T cells in the LN. T cells in control mice without skin
inflammation showed some proliferation in response to OVA
indicating an inefficient presentation of peptides on MHC-
class II by DC in the draining LN. In contrast, application of
the contact allergen prior to OVA resulted in a dramatically
increased Tcell proliferation in vivo, as most of the CFSEþ T
cells had started to proliferate and some had divided up to
six times (Fig 6B, C). The application of lower concentra-
tions of OVA (500 mg) gave similar results (data not shown).
Antigen-specific T cells respond to rechallenge with
OVA In the next step, we wanted to know whether we
would observe signs of tolerance when applying OVA in the
absence of an inflammatory stimulus, i.e., in the steady
state. Mice were injected with antigen-specific OT-II T cells
and 24 h later OVA was applied onto the epidermis of these
mice with or without contact allergen pre-treatment. We
determined the numbers of transgenic Tcells in the LN up to
21 d after the first antigen application. As expected, the
Figure 4
Langerhans cells (LC) in the skin-draining lymph nodes produce
more interleukin (IL)-12 in an inflammatory situation. Lymph nodes
were digested with collagenase 48 h after epicutaneous application of
the contact allergen 2,4,6-trinitro-1-chlorobenzene (TNCB) and dendri-
tic cells (DC) were enriched on a Nycodenz gradient. DC were either
stimulated for 4 h with 100 ng per mL lipopolysaccharide (LPS) plus 5
mg per mL anti-CD40 monoclonal antibodies (mAb) or left unstimulated
in medium in the presence of Brefeldin A. Cells were stained with anti-
CD11c-APC (allophycocyanin) and anti-Langerin-fluorescein is-
othiocyanate (mAb 929F3) to identify LC and further examined for pro-
duction of the cytokines IL-12p40/70 (A, n¼5), tumor necrosis factor-a
(TNF-a) (n¼4), and IL-10 (C, n¼ 4). LC are defined as CD11cþ /
Langerinþ cells; resident/dermal DC as CD11cþ /Langerin cells. Lines
connect data points from individual experiments. N.S. po0.05.
Figure5
More activated T cells from lymph nodes draining inflamed skin
produce interferon-c (IFN-c). Lymph node cell suspensions were pre-
pared 48 h after application of contact allergen. (A) T cells were re-
trieved from the pellet after Nycodenz-gradient centrifugation and
immediately stained with monoclonal antibodies (mAb) against the ac-
tivation markers CD25 and CD69. After fluorescence activated cell
sorting analysis the absolute numbers of activated T cells per lymph
node were calculated. n¼ 3; po0.005. (B) For detection of cytokines
T cells were stimulated overnight with 3 mg per mL immobilized anti-
CD3 and 3 mg per mL soluble anti-CD28 mAb in the presence of 30 U
per mL IL-2. Brefeldin A was present during the last 4 h of stimulation.
CD4 T cells and CD8 T cells were gated and examined for IFN-g pro-
duction. Lines connect data points from individual experiments. All five
experiments are shown. po0.05; po0.005.
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numbers of T cells increased after induction of inflammation
(i.e., in response to application of TNCB) in the skin and
dropped to low numbers within 21 d. The numbers of
transgenic T cells, however, in the mice immunized with
OVA in the steady state (i.e., without TNCB pre-treatment)
remained similar and did not decrease markedly, indicating
that these T cells were not deleted (Fig 7A). When we re-
challenged the mice with OVA plus contact allergen on day
8 or day 21 after the first immunization we observed similar
proliferation of transgenic T cells regardless of whether the
initial immunization was performed with or without contact
allergen. Thus, immunization with OVA in the steady state,
i.e., in the absence of an inflammatory stimulus, did not
prevent proliferation of transgenic T cells indicating that the
transgenic T cells did not become anergic in this experi-
mental setting (Fig 7B,C).
Figure 6
Lymph node dendritic cells (DC) stimulate stronger antigen-
specific proliferation of T cells when the skin is inflamed. (A) One
milligram of ovalbumin (OVA) was applied onto the epidermis of un-
treated or 2,4,6-trinitro-1-chlorobenzene (TNCB)-treated (1 h prior
to antigen application) mice and lymph node DC were sorted 48 h
later with anti-CD11c-MACS beads. Graded doses of DC were
co-cultured with 1  105–2  105 transgenic T cells isolated from
OT-II mice for 24–72 h. During the last 16 h, cells were pulsed with
H3-thymidine to measure proliferation of T cells. One experiment is
shown out of three. (B) T cells from antigen-specific OT-II mice were
isolated and labeled with 2 mM CFSE prior to intravenous inject-
ion. Twenty-four hours later 1 mg OVA in creme was applied onto
the ear skin of either untreated or contact allergen-treated mice
(1 h prior to antigen application). Cell suspensions from the draining
lymph nodes were prepared 3 d after antigen application and examined
for T cell proliferation, as measured by a decrease/dilution of CFSE
intensity. One representative experiment is shown out of 4. (C)
Same protocol as above but all four experiments (representing data
from eight individually analyzed mice per experimental group) are
summarized. po0.005.
Figure7
Topical application of ovalbumin (OVA) in the absence of an in-
flammatory stimulus does not induce tolerance. We injected
CFSEþ transgenic CD4þT cells intravenously into mice and 24 h later
we applied either phosphate-buffered saline (PBS) or 1 mg OVA protein
with or without contact allergen 2,4,6-trinitro-1-chlorobenzene (TNCB)
(1 h prior to antigen application) epicutaneously. (A) On d8 or d21
numbers of remaining transgenic T cells (CFSEþCD4þ ) in the lymph
nodes were determined in these mice. Absolute numbers of transgenic
Tcells per lymph node are shown. n¼3. (B) On d8 or d21 mice were re-
immunized topically with 1 mg OVA and TNCB, and in vivo proliferation
of Tcells was assessed by dilution of CFSE intensity 3 d later. Summary
of two experiments is shown; Each bar represents one individual
mouse. (C) One representative experiment is shown out of three.
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Discussion
As opposed to non-epidermal types of DC, the in vivo role
of LC in the generation of immunity as well as the mainte-
nance of peripheral tolerance is largely unknown (Steinman
et al, 2003). Anti-Langerin/CD207 antibodies allowed us for
the first time to selectively study LC, rather than a mixed
population of LC and dermal DC, in the induction of immune
responses or tolerance via the skin. We contribute here a
number of observations that may help elucidate the role of
LC. The LC that migrate from the epidermis in the steady
state and can be identified in the draining LN do not express
a phenotype that would clearly distinguish them from im-
munity-inducing LC that migrate under inflammatory con-
ditions as provoked by the contact allergen TNCB. They do,
however, display different cytokine-production profiles (less
IL-12) and they induce less antigen-specific T cell prolifer-
ation in vitro and in vivo.
Proﬁles of co-stimulatory and maturation-associated
molecules on LC CD40 and most of the B7 family mem-
bers were already expressed on a part of the LC in the
steady-state LN. The inflammatory stimulus led to higher
absolute numbers of LC expressing higher levels of these
molecules on the surface. Some recent publications are in
line with these findings. We have previously observed the
maturation-associated molecule 2A1 on most LC in steady-
state skin-draining LN in situ (Stoitzner et al, 2003). Ruedl
et al (2000) and Henri et al (2001) demonstrated further that
the putative LC population in the steady-state skin-draining
LN expresses high levels of CD40, thus not representing
true immature DC. Wilson et al (2003) recently reported that
the skin-derived DC population (dermal DC and LC) in the
LN displays features of maturation as determined by pheno-
type and function in contrast to resident LN DC. Finally, it
was shown that also in the steady state migrating DC, in
general, and LC, in particular need CCR7, a receptor com-
monly associated with maturation (Ohl et al, 2004). These
data indicate that LC start maturing during migration to the
LN in the steady state and that migration is coupled with
several but not all features of maturation (Randolph, 2002).
Our data complement and extend the cited observations in
that—to the best of our knowledge—we have analyzed the
phenotype specifically of LC for the first time and we have
expanded the panel of co-stimulators analyzed.
Our observations with LC are also in accordance with
data by Hawiger et al, who induced tolerance by targeting
antigen to DC in the steady state. The tolerogenic DC ex-
pressed substantial levels of CD40 and CD86. Tolerance
was overcome by simultaneous injection of anti-CD40 mAb
and was accompanied by a slight upregulation of CD40 and
CD86 (Hawiger et al, 2001), similar to our observations with
LC. In summary, these observations emphasize that mat-
uration of DC in general and LC in particular is a complex
process. Therefore, the mere presence or absence of some
phenotypical maturation markers such as CD40, CD86, or
2A1 does not necessarily mean that such DC/LC are
immunogenic or tolerogenic, respectively.
Data from Geissman et al, who reported that Langerinþ
cells in the LN of patients with dermatopathic lymphadenitis
were phenotypically immature expressing no maturation
markers like CD83, CD86, and CD208/DC-LAMP (Geiss-
mann et al, 2002), appear to be at variance with the obser-
vations in the mouse. But explanations for this discrepancy
could be a species difference or, more likely, the possibility
that the Langerinþ cells in the samples from patients with
chronic skin inflammation are different from the steady-
state situation.
Proﬁles of potentially T cell-inhibitory molecules on
LC Some members of the B7 family of co-stimulatory mol-
ecules such as B7-H1/PD-L1 and B7-DC/PD-L2 (Freeman
et al, 2000; Latchman et al, 2001), as well as ICOS-ligand/
B7-H2 (Witsch et al, 2002) are involved in T cell inhibition
and tolerance. We hypothesized that these molecules might
be upregulated in the steady state and therefore examined
their expression and regulation on LC in skin-draining LN.
The inverse was found to be the case. Rather than being
expressed at higher levels in the steady state, the two PD-L
molecules were distinctly upregulated during inflammation.
This is in accordance with data published by Freeman et al
(2000) and Liang et al (2003) showing that activated DC
increase expression of PD-L molecules suggesting a ‘‘coun-
terbalancing’’ role in the downregulation of ongoing immune
responses. Furthermore, ICOS-L was never expressed on
LC in the LN. Witsch et al reported that ICOS-L is expressed
on human LC in situ allowing them to induce production of
IL-10 in T cells (Witsch et al, 2002). We observed low ICOS-
L expression on DC in the LN, but these few cells were
clearly Langerin. In summary, it may be concluded from
our experiments that LC in the steady-state LN display no
distinct ‘‘tolerogenic’’ phenotype in that they would express
higher levels of T cell inhibitory co-stimulator molecules or
IL-10-inducing molecules.
Functional properties of LC-cytokine production As the
phenotypical differences between LC in LN in the steady
state and inflammation turned out to be subtle we further
examined these cells at a functional level. Cytokine produc-
tion by LC in LN has not been studied so far. The major
observation was that during inflammation, LC in the LN pro-
duced more IL-12 than in the steady state, and that pro-
portionally more LC than Langerin DC in the LN produced
IL-12. Consequently, the corresponding T cells in LN drain-
ing inflamed skin expressed more of the activation markers
CD25 and CD69, and they produced more IFN-g. IL-12 in-
deed plays a role in the induction of contact sensitivity
in vivo, that is, in the very model used in this study. The
mRNA for the IL-12p40 chain was detected in LN 12–14 h
after application of 1% TNCB onto the skin, and it was
shown by in situ hybridization that DC were the producers in
the LN (Mu¨ller et al, 1995). Hochrein et al (2001) reported that
CD8aþDC from skin-draining LN produce IL-12p70 upon
stimulation with CD40 ligand and LPS, whereas DC ex-
pressing low amounts of CD8a produce less IL-12p70. Fur-
thermore, Curtsinger et al (2003) demonstrated that IL-12 as
signal 3 determines the discrimination between tolerance or
full activation of CD8þT cells. Thus, the presence or ab-
sence of high levels of IL-12 may be a crucial factor in the
DC’s decision between induction of immunity or tolerance.
The pro-inflammatory cytokine TNF-a was produced by
Langerin DC and LC in skin-draining LN in small amounts.
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TNF-a was upregulated during inflammation in Langerin
DC only and not in LC leading to an overall increase in pro-
inflammatory cytokines in the skin-draining LN during in-
flammation.
IL-10, a cytokine involved in tolerance (Steinman et al,
2003), was only detectable in small amounts in the LN and
IL-10 production by DC appeared not to be regulated during
inflammation. Furthermore, the T cells in the skin-draining
LN in the steady state produced no IL-4 and no IL-10. Thus,
we could not detect a ‘‘tolerizing cytokine mileu’’ in the
steady-state skin-draining LN as observed in the lungs and
intestines (Iwasaki and Kelsall, 1999; Akbari et al, 2001).
Functional properties of LC T cell-stimulation The al-
tered cytokine production implicates a difference in T cell
stimulation in skin-draining LN. It is not possible to sort the
LC from LN because of the lack of specific surface markers.
Langerin is internalized quickly into maturing LC and there-
fore does not allow isolation of the entire population of LN
LC. Proliferation of antigen-specific CD4þTcells in vitro was
found to be clearly enhanced when the immunized skin was
inflamed. These in vitro results were confirmed in in vivo
proliferation assays in which stronger and more prolonged
antigen-specific T cell proliferation was observed during in-
flammation, too. The assistance of dermis-derived DC in
antigen presentation cannot be excluded as it is not known
to what extent the contact allergen activates dermal DC as
well. Streilein (1989) and Tse and Cooper (1990) reported
that dermal DC can induce contact sensitivity as well as
LC; thus, a possible involvement of dermal DC must be
considered.
Other groups demonstrated that epicutaneous immuni-
zation with MHC-class I-restricted peptides induced devel-
opment of cytotoxic T cells. Inflammation of the skin, such
as tape stripping, which leads to disruption of the stratum
corneum barrier, was essential. LC isolated from tape-
stripped skin expressed higher levels of MHC-class I mol-
ecules and co-stimulators and thus were stronger in in-
duction of CTL in vitro than LC from intact skin (Seo et al,
2000). Consequently, epicutaneous immunization through
intact, non-inflamed skin did not lead to immunity. A pos-
sible development of tolerance was not tested. Kahlon et al.
observed similar CTL activity after immunization with an
MHC-class I-restricted peptide or with OVA protein onto
tape-stripped skin. Co-administration of cholera toxin fur-
ther increased the immune response (Kahlon et al, 2003).
Thus, epicutaneous immunization induces responses in T
cells in the draining LN, but for an optimal response inflam-
mation in the skin is necessary. These data together with
our results suggest that most likely these responses are
induced by epidermal LC. It remains to be determined
whether dermal DC contribute to this activity.
Tolerance induction by LC Using a transgenic model and
melanin as a self-antigen it was clearly shown that LC carry
self-antigens from the skin to the LN in vivo in the steady
state (Hemmi et al, 2001). Likewise, we detected LC car-
rying melanin or apoptotic bodies in dermal lymph vessels
in a skin explant model (Stoitzner et al, 2003). Thus, self-
antigens are transported to LN by LC from skin both in
inflammation and in the steady state. It was not studied,
however, if in the steady state these antigens are presented
to T cells in the LN in a tolerogenic fashion. In our setting,
transgenic T cells in mice immunized with OVA protein
without an inflammatory stimulus were not deleted when we
followed them up until 21 d. Furthermore, when mice were
rechallenged with OVA and contact allergen we observed
similar CD4 T cell proliferation regardless of whether initial
immunization was carried out in the absence or presence of
inflammation. This indicates that in this model, the Tcells do
not become anergic and can respond to the antigen in an
unimpaired fashion when they encounter it for a second
time, at least in the context of another strong inflammatory
stimulus. The likely interference of dermal DC in these ex-
periments, however, precludes the conclusion as to the in-
ability of migratory LC in the steady state to induce or
maintain tolerance. Further studies need to be performed
with antigens expressed in the skin such as in the following
two recent reports. In a model where an antigenic OVA
peptide is expressed under the K14 promoter, LC were not
able to induce tolerance in adoptively transferred antigen-
specific CD8þT cells (Mayerova et al, 2004). Likewise, in
mice in which the whole OVA protein was expressed in the
epidermis adoptively transferred CD8þT cells induced a
GvH-like disease rather than being silenced by antigen-
carrying LC (Shibaki et al, 2004). But if these same mice
were immunized with OVA into the skin, no delayed type
hypersensitivity reaction developed indicating that the mice
were rendered tolerant, presumably by LC migrating in the
steady state and cross-presenting the antigen to the en-
dogenous antigen-specific T cells (Shibaki et al, 2004).
Shortman and Heath (2001) discuss that the completion
of the maturation process (‘‘more of the same’’) may be the
determining factor for induction of tolerance versus immu-
nity: short-lived, incompletely mature DC, rather than im-
mature DC would induce tolerance and fully activated DC
immunity. The virtual absence of immature LC in skin-drain-
ing LN would support this notion, suggesting that not fully
mature LC with moderate levels of costimulators and low
cytokine production induce weak T cell proliferation or even
tolerance. In contrast, fully mature LC with maximum levels
of co-stimuli and high cytokine production stimulate strong
T cell proliferation and thus immunity.
Materials and Methods
Mice Mice of inbred strains C57BL/6, BALB/c, and OT-II were
purchased from Charles River Germany, Sulzfeld, Germany, and
used at 2–12 mo of age. CD4þT cells from OT-II mice express a
transgenic Va2Vb5 TCR specific for the OVA peptide 323–339 in
the context of I-Ab (Barnden et al, 1998). All animal experiments
were carried out according to the Institutional Review Board.
Antibodies for phenotypical studies For detection of LC we
used two different antibodies against mouse Langerin: a mAb
recognizing Langerin in its intracellular conformation (929F3-
fluorescein isothiocyanate (FITC), rat immunoglobulin G1 (IgG1)
(Stoitzner et al, 2003) and another mAb binding to an extracellu-
lar part of Langerin exposed at the cell surface (205C1-FITC,
mouse IgM, Douillard et al, manuscript in preparation). For detec-
tion of intracellular Langerin, the cells were permeabilized with the
Perm/Wash kit from BD-Pharmingen (San Diego, California). The
following antibodies were purchased from BD-Pharmingen: CD40-
FITC/-phycoerythrin (PE) (clone 3/23), CD86-FITC/-PE (clone
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GL-1), CD80-PE (clone 16–10A1), CD11c-APC (HL3), MHC-class
II-biotinylated/-FITC/-PE (clones 2G9 and M5/115), IL-12p40/70-
PE (clone C15.6), IL-10-PE (clone JES5-16E3), CD4-FITC/-APC
(clone L3T4), CD8a-FITC/-APC (clone Ly-2), IL-4-PE (clone BVD4-
24G2), TNFa-PE (MP6-XT22), IFN-g-APC (clone XMG1.2), CD69-
biotinylated (clone H1.2F3), CD25-PE (clone 3C7), Va2 TCR-PE
(clone B20.1), V5.1/5.2 TCR-biotinylated (MR9-4), goat anti-rat Ig-
PE, and Streptavidin-PerCP. Other mAb against B7-family mem-
bers were purchased from eBioscience (San Diego, California): B7-
DC-PE (clone TY25), B7-H1-PE (clone MIH5), ICOS-L-PE (clone
HK5.3).
Induction of inﬂammation in the skin with a contact aller-
gen Mice were anesthetized with an intraperitoneal injection of
vetanarcol (Veterinaria AG, Zu¨rich, Switzerland). Abdominal skin
was shaved with an electric razor followed by the application of
250 mL of 1% TNCB (picryl-chloride) (Kodak Eastman, Rochester,
New York). Murine ear skin was treated with 15 mL 1% TNCB on
both sides (dorsal and ventral) resulting in 30 mL per one ear. The
contact allergen TNCB was dissolved in acetone:olive oil (4:1).
Isolation of LN DC Skin-draining LN (auricular and inguinal) were
excised 48 h after application of the contact allergen. Cell sus-
pensions from LN were prepared by digestion with 0.5 mg per mL
collagenase P (Roche, Mannheim, Germany) for 30 min at 371C
and subsequent pressing of the tissue through cell strainers (70
mm, Falcon Labware, Oxnard, California), essentially as described
recently for spleen cell suspensions (McLellan et al, 2002). For
most of the experiments, DC were enriched by Nycodenz gradient
centrifugation (Sigma-Aldrich, St Louis, Missouri) as described
(McLellan et al, 1995). DC were stained with the above-mentioned
mAb to investigate differences in phenotype between contact al-
lergen-treated and untreated control mice.
Detection of intracellular cytokines DC and Tcells were isolated
from lymph nodes by collagenase digestion. DC were further en-
riched with a Nycodenz gradient and stimulated for 4 h with 100 ng
per mL LPS (Sigma-Aldrich) and 5 mg per mL anti-CD40 mAb
(clone H3/23, BD-Pharmingen) to augment cytokine production of
IL-12, IL-10, and TNF-a. To prevent secretion of cytokines 1 mg per
mL Brefeldin A (BD-Pharmingen) was added during the whole
stimulation period. Lymph node T cells were stimulated by over-
night culture with immobilized anti-CD3 mAb (3 mg per mL, clone
17A2, BD-Pharmingen) and soluble anti-CD28 (3 mg per mL, clone
37.51, BD-Pharmingen). To improve survival of the T cells during
overnight culture, the medium was supplemented with 30 U per mL
IL-2. Brefeldin A at 1 mg per mL was added for the last 4 h of the
culture to stop cytokine secretion. For fluoro cytometry analyses,
cells were permeabilized with a cell permeabilization kit (An der
Grub, Vienna, Austria) and stained with the above-mentioned mAb
to detect cytokines in DC and T cells. In cell suspensions from
lymph nodes, LC were identified by double labeling with anti-
CD11-APC and anti-Langerin–FITC mAb (clone 929F3).
In vitro OVA-specific T cell proliferation assay We applied 1 mg
OVA in 20 mL aqueous creme (hydrophilic oil in water emulsion,
Ultrasicc, Hecht Pharma GmbH, Stinstedt, Germany) onto the ear
skin of either untreated or TNCB-treated mice (treated 1 h prior to
antigen application). DC were isolated 48 h later from draining au-
ricular lymph nodes by collagenase digestion of the tissue. DC
were further enriched on a Nycodenz-gradient followed by CD11c-
magnetic bead sorting (Miltenyi Biotec, Bergisch Gladbach, Ger-
many). DC purity ranged between 70% and 90% after MACS
sorting. T cells were isolated from spleens and lymph nodes of OT-
II transgenic mice and further purified by negative selection. Cell
suspensions were incubated with a lineage cocktail consisting of
mAb against anti-MHC II (clone M5.114), anti-CD45RA (clone
B220), anti-Ly-6C (clone Rb6), anti-heat stable antigen (clone M1/
69), anti-NK1.1 (clone 4D11), and anti-CD8 (clone Lyt-2) followed
by anti-rat/anti-mouse IgG coupled to Biomag-beads (Qiagen, Hil-
den, Germany). Negative fractions were collected and contained
over 90% CD4þ T cells. Graded doses of DC were incubated with
2  105 OVA-specific transgenic OT-II T cells for 24–72 h. Prolif-
eration of T cells was measured by incorporation of tritiated thy-
midine within the last 16 h.
In vivo proliferation assays As described above, T cells were
isolated from TCR transgenic OT-II mice and labeled with 2 mM
CFSE (Molecular Probes, Leiden, the Netherlands). C57BL/6 mice
were injected intravenously with 2  106–3  106 CFSE-labeled
OT-II T cells. Twenty-four hours thereafter, 1 mg OVA, dissolved in
20 mL of aqueous creme was applied topically onto the epidermis
of either untreated or contact-allergen-treated mice (treated 1 h
prior to antigen application). Cell suspensions were prepared 72 h
thereafter by pressing the auricular lymph nodes through cell
strainers with the plunger of a syringe. Four separate experiments
were performed. In each of these experiments, two mice were
used per experimental condition. Draining auricular lymph nodes of
each mouse were pooled. The proliferation of antigen-specific
CFSEþOT-II T cells was detected by the progressive dilution of
CFSE fluorescence intensity as described earlier (Lyons, 2000).
In some experiments, we challenged mice on day 8 or day 21
after first application of antigen and lymph node cells were exam-
ined for T cell proliferation 3 d later.
Statistical analysis Appropriate statistical tests (either t test or
Mann–Whitney U test) were used to analyze the data.
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FigureS1 Langerhans cells still expressing Langerin extracellularly in
the lymph node show a mature phenotype.
FigureS2 Langerhans cells in the skin-draining lymph nodes produce
more IL-12 in an inflammatory situation.
FigureS3 More activated T cells from lymph nodes draining inflamed
skin produce IFNg.
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